6 terminated. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 6 |
| Phase 2 | 2 | Terminated 2 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension Latanoprost eluting contact lens, Topical Latanoprost - Glaucoma, Ocular Hypertension | Phase 1 | Terminated | Massachusetts Eye and Ear Infirmary | 1 | 2024-04-03 | 2025-10-15 |
| Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma TimoD implant, Injector system - Primary Open-angle Glaucoma | Phase 1 | Terminated | EyeD Pharma | 1 | 2023-03-01 | 2025-07-16 |
| Macular Pigment and Visual Performance in Glaucoma Patients Lutein, zeaxanthin and mesozeaxanthin, Placebo - Glaucoma | Phase 1 / Phase 2 | Terminated | Felipe Medeiros, MD | 8 | 2019-08-21 | 2023-01-03 |
| Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy GlaucoHealth, GlaucoSelect, Placebo - Open-angle Glaucoma, Diabetic Retinopathy | Phase 1 | Terminated | The New York Eye & Ear Infirmary | 21 | 2016-04-15 | 2021-03-17 |
| Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension DWT device dose A, Ellex Tango SLT machine, DWT device dose B - Primary Open-angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 1 / Phase 2 | Terminated | OcuTherix, Inc. | 35 | 2013-11-01 | 2017-04-04 |
| Safety Study of Latanoprost Slow Release Insert Latanoprost, Arm 2, Latanoprost SR insert - Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 1 | Terminated | Daniel Moore | 12 | 2011-01-01 | 2014-12-08 |
Glaucoma, Open-Angle (4) · Ocular Hypertension (3) · Diabetic Retinopathy (1)
Eye Diseases (6) · Ocular Hypertension (3) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Retinal Diseases (1) · Vascular Diseases (1)
Latanoprost (2) · DMAC2L protein, human (1) · Drugs, Investigational (1) · Lutein (1) · Zeaxanthins (1)
Daniel Moore (1) · EyeD Pharma (1) · Felipe Medeiros, MD (1) · Massachusetts Eye and Ear Infirmary (1) · OcuTherix, Inc. (1) · The New York Eye & Ear Infirmary (1)
United States (4) · Germany (1) · Philippines (1)
Daniel B. Moore, M.D. (1) · David S Friedman, MD, PhD, MPH (1) · Edgar U. Leuenberger, MD (1) · Felipe A Medeiros, MD, PhD (1) · Harvey Siy Uy, MD (1) · Maria I Yap-Veloso, MD (1) · Robert Ritch, MD (1)